Gene Query: HINT3

Dataset Description Geneva Score
RNA-seq from control and macroH2A1-depleted IMR90 primary human lung fibroblasts 265.72
Exploring the role of macroH2A1 in transcription regulation in IMR90 primary human lung fibroblasts with RNA-seq and ChIP-seq 265.72
A radiolabeling-free, qPCR-based method for locus-specific pseudouridine detection 205.35
Peptidomimetic blockade of MYB in acute myeloid leukemia [RNA-seq] 193.21
Peptidomimetic blockade of MYB in acute myeloid leukemia 193.21
Genome wide mapping of polyadenylation sites in proliferating and contact-inhibited cells and cells with knockdown of cleavage and polyadenylation factors 143.6
Selective roles of vertebrate PCF11 in premature and full-length transcript termination (chromatin-bound RNA-seq) 113.09
Virus Mimicry in the Tumor Microenvironment Activates RIG-I Through Unshielding of Endogenous RNA in Exosomes [RNA-Seq] 93.7
Transcriptome sequencing wide functional analysis of human mesenchymal stem cells (Poly(I:C) and LPS) 90.47
Nm-seq finds thousands of modified 2’-O-methylation sites in mRNA with base precision 87.35
DDX54 regulates transcriptome dynamics during DNA damage response [RNA-seq2] 70.91
HNRNPL and its RNA Targets in Prostate Cancer 67.5
Regulartory effect of HNRNPL and LARP on RNA expression in LNCaP prostate cancer cells 67.5
Functional characterization of human T cell hyporesponsiveness induced by CTLA4-Ig 67.11
TimeLapse-seq: adding a temporal dimension to RNA sequencing through nucleoside recoding 60.27
Differentiation enhances Zika virus infection in neuronal brain cells 42.72
RNA-seq of cultured human kidney peritubular microvascular endothelial cells following exposure to cyclosporine A 41.98
Argonaute proteins couple chromatin silencing to alternative splicing (RNA IP-Seq) 38.73
Argonaute proteins couple chromatin silencing to alternative splicing 38.73
Next Generation Sequencing upon siRNA-mediated knockdown of EIF5A in MCF-7 cells. 38.68
Global analysis of pre-mRNA subcellular localization upon splicing inhibition by spliceostatin A 37.29
mTORC1 balances cellular amino acid supply with demand for protein synthesis through post-transcriptional control of ATF4 37.24
Global analyses of the effect of different cellular contexts on microRNA targeting 37.03
Global analyses of the effect of different cellular contexts on microRNA targeting (RNA-Seq) 37.03
Uridylation-mediated RNA quality control pathway in mammalian cytoplasm [RNA-Seq] 35.91
TUT-DIS3L2 is a mammalian surveillance pathway for aberrant structured non-coding RNAs. 35.91
miR-191 regulates human cell proliferation and directly targets multiple oncogenes [seq] 35.48
Genome wide miR-191 target profile determined by RIP and gene expression profiling 35.48
Transcriptome analysis revealed impaired cAMP responsiveness in PHF21A-deficient human cells 33.14
TT-Seq captures the human transient transcriptome 32.93
Chromatin accessibility landscape upon induction of Msgn1, Pax3 and Myf5 in mesodermal cells and identification of conserved Pax3 binding sites and target genes during skeletal myogenesis 32.4
Characterizing smoking-induced transcriptional heterogeneity in the human bronchial epithelium at single-cell resolution 31.82
Deciphering the ‘m6A code’ via quantitative profiling of m6A at single-nucleotide resolution 29.55
Deciphering the ‘m6A code’ via quantitative profiling of m6A at single-nucleotide resolution [III] 29.55
Comprehensive RNA-Seq profiling in PBMCs of ALS patients and healthy controls 29.38
RNA-Seq profiling in PBMCs and spinal cord from ALS patients and healthy controls 29.38
Tracing the temporal-spatial transcriptomic landscapes of the human fetal digestive tract by single cell RNA-seq analysis [adult tissues] 27.59
Limiting cholesterol biosynthetic flux engages type I IFN signaling in a STING-dependent manner 26.61
An alternative CTCF isoform antagonizes canonical CTCF occupancy and changes chromatin architecture to promote apoptosis 26.2
Transcriptomic profiling of human CD34+ derived mast cells [RNA-Seq] 26.02
Landscape of human mast cell chromatin: a rich resource for identification of novel mediators and genetic drivers of allergic and inflammatory diseases 26.02
Control of human hemoglobin switching by LIN28B-mediated regulation of BCL11A translation 25.87
Presence of NAD+-capped RNA in human cells: function and removal by the DXO deNADing Protein 25.66
Efficient and quantitative high-throughput tRNA sequencing 24.8
Aortic Valve Tissue: Stenosis vs. Sclerosis 24.33
Ribosomal footprinting of MDA-Parental and MDA-LM2 23.26
m6A-dependent regulation of messenger RNA stability 22.7
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia [mutant MEF2C] 19.83
Genome-wide analyses of chromatin state in human mast cells reveal molecular drivers and mediators of allergic and inflammatory diseases 19.77
Transcriptomic profiling of human peripheral blood-derived mast cells 19.77
Transcriptomic profiling of normal human cardiac fibroblast treated with halofuginone 19.43
Detection of internal N7-methylguanosine (m7G) RNA modifications by mutational profiling sequencing 18.64
Exploring the RNA landscape of endothelial exosomes 18.5
Apoptotic endothelial cells release small extracellular vesicles loaded with immunostimulatory viral-like RNAs 18.3
Radiomic and gEnomic approaches for the enhanced DIagnosis of REnal Cancer (REDIRECt): A translational pilot study 18.03
Genome-wide expression profiling of B Lymphocytes reveals IL4R increase in allergic asthma 17.82
The human blood-nerve barrier transcriptome 17.68
Transcriptomic analysis of human tonsillar TFH subsets 17.37
Global expression profiles in cardiac progenitor cells generated by ISX-9 17.28
Global mRNA expression profile in cardiac progenitor cells generated by ISX-9 17.28
Patterned human microvascular grafts enable rapid vascularization and increase perfusion in infarcted hearts 16.64
ONECUT2 Drives Neuroendocrine Prostate Cancer Through Hypoxia Signaling 16.51
Distinct roles of cohesin-SA1 and cohesin-SA2 in 3D chromosome organization  16.51
PTBP1 excludes UPF1 to protect long 3'UTRs from nonsense-mediated mRNA decay 16.18
Base-resolution mapping reveals distinct classes of N1-methyladenosine methylome in nuclear- and mitochondrial-encoded transcripts 16.04
Identification of transcription start sites for human A549 cell line using ReCappable-seq 15.73
Control of human hemoglobin switching by LIN28B-mediated regulation of BCL11A translation (Ribo-seq, RNA-seq) 15.59
Next Generation Sequencing upon siRNA-mediated knockdown of DRAIC in MCF-7 cells. 15.58
Analysis of transcriptome changes following SOX2 knockdown in three different Ewing sarcoma cell lines 14.97
Amiloride, an old diuretic drug, is a potential therapeutic agent for multiple myeloma 14.94
MYC dependent mRNA translation shapes gene expression and cell biology 14.86
DHX15 regulates CMTR1-dependent gene expression and cell proliferation 14.53
Ultracentifugation and nanoscale deterministic lateral displacement (nanoDLD) of samples for exRNA analysis 14.24
Proteotranscriptomic profiling of potential E6AP targets in prostate cancer cells 14.17
The ARID1A tumor suppressor controls global transcription via pausing of RNA Polymerase II 14.12
RNA helicase A is necessary for KIF1Bβ tumor suppression in neuroblastoma 13.95
Transcriptomic analysis of T84 colon carcinoma cell line treated with trametinib, JQ1 or their combination 13.88
Short and Long RNA sequencing of human mature erythrocytes 13.48
Mutually Exclusive CBC-Containing Complexes Contribute to RNA Fate. 13.45
Lipid catabolism inhibition sensitizes prostate cancer cells to antiandrogen blockade 13.34
HeLa transcriptome induction by IFN gamma and indoleamine 2,3-dioxygenase (IDO) 13.25
AZ1366: An inhibitor of tankyrase and the canonical Wnt pathway that limits the persistence of non-small cell lung cancer cells following EGFR inhibition 13.25
RNA-seq of MCF10A cells and CAF 12.75
Epigenomic plasticity enables human pancreatic alpha to beta cell reprogramming 12.62
GREB1 amplifies androgen receptor output in prostate cancer and contributes to antiandrogen resistance 12.62
RNA sequencing of Formalin-Fixed, Paraffin-Embedded Specimens for Gene Expression Quantification and Data Mining 12.43
miR-93 Targets in Human Endothelial Cells 12.3
RNA G-quadruplexes mark repressive upstream open reading frames in human mRNAs 12.21
Inducible three-factor direct reprogramming to nephron progenitors using piggyBac transposons 12.2
RNA transcriptome analysis during HSV-1 infection 12.15
Gene expression profiles of tumor-infiltrating CD8 T cells in hepatocellular carcinoma 12.13
RNA-seq analyisis of PUM2 knockout cells 11.87
High-throughput sequencing of pluripotent cells 11.75
Ribosomal footprinting of MDA_Ctrl and MDA_Arg overexpression cell lines 11.73
Heterozygous p53-R280T mutation promotes proliferation of NPC cells through activating PI3K/Akt signaling pathway 11.72
Global unleashing of transcription elongation waves in response to genotoxic stress restricts somatic mutation rate 10.96
A large panel of isogenic APP and PSEN1 mutant human iPSC neurons reveals shared endosomal abnormalities mediated by APP b-CTFs, not Ab [ribosome profiling] 10.83
Transcriptome-profiling (RNA-seq) and Ribosome-profiling (Ribo-seq) of BJ cells treated with Nutlin-3a, an MDM2 inhibitor, which induces p53. 10.76
Post-transcriptional manipulation of TERC reverses molecular hallmarks of telomere disease 10.75
Transcriptome analysis of reticulated platelets reveals a prothrombotic profile [mRNA-Seq] 10.62
Transcriptome analysis of reticulated platelets reveals a prothrombotic profile 10.62
Discovery of cis-spliced chimeric RNAs between adjacent genes in human prostate cells 10.59
RNA G-quadruplexes cause eIF4A-dependent oncogene translation in cancer 10.55
Characterization of transcriptomics landscape in HUVEC cells exposed to oxidative stress 10.53
Human cell line and subcutaneous tumor 10.51
Transcriptomics analysis of gene expression in normal and METTL3 or WTAP deficient Human HeLa cells 10.48
Distinct and shared functions of ALS-associated TDP-43, FUS, and TAF15 revealed by comprehensive multi-system integrative analyses [RNA-Seq_Stability] 10.44
Paxillin regulates genomic networks in prostate cancer [LNCaP] 10.36
Cohesin and CTCF Differentially Affect the Chromatin Architecture and Gene Expression in Human Cells 10.26
Next Generation Sequencing Facilitates Quantitative Analysis of miR-29b-1 and miR-29a targets in tamoxifen-sensitive and tamoxifen-resistant human breast cancer cells 10.18
Isolation and sequencing of AGO-bound RNAs reveals characteristics of stem-loop processing in vivo 10.15
Regulation of mRNA half-life by an inhibitor of human decapping enzyme Dcp2 following transcription shutoff in HEK293T cells 10.11
transcriptomic profiling of HEK293 cells upon individual knockdown of the splicing factors RBM17, U2SURP or CHERP 9.98
Activation of neuronal genes via LINE-1 elements upon global DNA demethylation in human neural progenitors 9.96
Tracking distinct RNA populations using efficient and reversible covalent chemistry 9.92
Activation of HOTTIP lncRNA perturbs HSC function leading to AML like disease 9.91
The Human Testis Cell Atlas via Single-cell RNA-seq 9.86
mRNA cap methyltransferase, RNMT-RAM, promotes RNA pol II transcription 9.82
Tyrosine-1 of RNAPII CTD controls global termination of gene transcription in mammals 9.65
LNCaP treated with iBET 9.64
BRG1 governs Glucocorticoid Receptor interactions with chromatin and pioneer factors across the genome 9.54
Comprehensive analysis of Long non-coding RNA expression in dorsal root ganglion reveals cell type specificity and dysregulation following nerve injury 9.42
Comprehensive analysis of Long non-coding RNA expression in dorsal root ganglion reveals cell type specificity and dysregulation following nerve injury [human iPS] 9.42
Understanding the reproducibility and robustness of the kidney organoid differentiation protocol using RNA-seq 9.05
RNA m5C Methylation in breast cancer using MeRIP-Seq 9.0
Bromodomain inhibition of the co-activators CBP/EP300 facilitates reprogramming 8.99
Bromodomain inhibition of the co-activators CBP/EP300 facilitates reprogramming (RNA-seq fibroblasts) 8.99
EIF1AX-A113 splice and RAS mutations cooperate to drive thyroid tumorigenesis through ATF4 and c-MYC 8.98
Targets of CDK12 on ZR-75-30 breast cancer cells (RNA-seq) 8.98
Transcriptome-wide identification of splicing defects upon XAB2 knockdown 8.92
Effect of CTCF and Rad21 knockdown on SLK cells and KSHV gene expression 8.9
Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock 8.8
Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock [RNA-Seq] 8.8
Fisetin induces autophagy in pancreatic cancer cells via endoplasmic reticulum stress- and mitochondrial stress-dependent pathways 8.7
Study functions of ADAR proteins using next generation sequencing of genome and transcriptome 8.57
ATF4 inhibition by p62 represses stromal metabolic reprogramming and tumorigenesis II 8.49
A SIRT1-centered Circuitry Regulates Breast Cancer Stemness and Metastasis 8.49
HOXC6 affects the malignant phenotype of esophageal squamous cell carcinoma cells 8.29
RNA-seq reveals abundant circRNA, lncRNA and mRNA in blood exosomes of patients with pancreatic carcinoma 8.28
hnRNP L protects mRNAs from nonsense-mediated mRNA decay 8.1
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 8.07
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 8.07
RC3H1 posttranscriptionally regulates A20 mRNA and modulates the activity of the IKK/NF-kB pathway [RNA-Seq] 7.97
RC3H1 posttranscriptionally regulates A20 mRNA and modulates the activity of the IKK/NF-kB pathway 7.97
Human Long Intergenic Noncoding RNA Linc-ADAL Knockdown in Mature Adipocytes using Lentiviral ShRNA 7.89
Priming mobilization of hair follicle stem cells triggers permanent loss of regeneration after alkylating chemotherapy 7.88
RNA-Seq of CD4+ T cells treated with AS1842856 or DMSO 7.82
Messenger RNA expression after silencing or inhibition of MEN1in MCF-7 breast cancer cells 7.71
Functional studies of missense TREM2 mutations in human stem cell-derived microglia 7.57
FMRP facilitates the nuclear export of N6-methyladenosine-containing mRNAs 7.43
Transcriptome analysis of genetically matched human induced pluripotent stem cells disomic or trisomic for chromosome 21 7.36
Human Nonsense-Mediated RNA Decay Initiates Widely by Endonucleolysis and Targets snoRNA Host Genes 7.24
The RNA-binding profile of Acinus, a peripheral component of the Exon junction complex, reveals its role in splicing regulation 7.2
Effect of disulfiram treatment on pediatric high grade glioma 7.2
Stem cell and neurogenic gene-expression profiles link prostate basal cells to aggressive prostate cancer 7.03
RNA-seq analysis of SLIRP knockdown with 1nM DHT in LNCaP cells 7.01
Simultaneous and systematic analysis of cellular and viral gene expression during Enterovirus 71-induced host shutoff 7.0
Low-Cell-Number, Single-Tube Amplification (STA) of RNAs Revealed miRNA Changes from Pluripotency to Endothelium 6.97
Next Generation Sequencing of isolated EGFR+ and HLA-G+ first trimester human trophoblasts 6.95
Ewing sarcoma resistance to SP-2509 is not mediated through KDM1A/LSD1 mutation I 6.94
LncRNA NMR knockdown and overexpression in esophageal squamous cell carcinoma cell lines 6.94
Ribosomal footprinting of CN34-Parental and CN34-LM1a 6.91
Biological effect of chronic mistranslation in mammalian cells 6.86
Genome-wide detection of DNase I hypersensitive sites in single cells and FFPE tissue samples 6.83
Montelukast counteracts the influenza virus-induced block in unfolded protein stress response and reduces virus multiplication 6.76
Biochemical fractionation of HEK293 nuclei and RNA-seq of chromatin-associated and soluble-nuclear RNA 6.76
A NIK-SIX signaling axis controls inflammation by targeted silencing of noncanonical NF-κB 6.72
Pervasive transcription read-through promotes aberrant expression of oncogenes and RNA chimeras in renal carcinoma 6.64
IQGAP3 interacts with Rad17 to activate the MRN/ATM/Chk2 signaling and promote radioresistance in lung cancer 6.63
Antiviral and anti-inflammatory properties of novel anti-HIV candidate ABX464 promotes specifics RNA splicing while preserving cellular RNA integrity. 6.6
Gene expression, methylome and splicing of THP-1 monocytic cells and THP-1-derived macrophage 6.59
Widespread N6-methyladenosine-dependent RNA Structural Switches Regulate RNA-Protein Interactions 6.54
BI Human Reference Epigenome Mapping Project 6.48
A large panel of isogenic APP and PSEN1 mutant human iPSC neurons reveals shared endosomal abnormalities mediated by APP b-CTFs, not Ab [RNA-seq] 6.44
Cutaneous Immunoprofile of Three Spotted Fever Group Rickettsiosis 6.42
RNA-sequencing experiment: Treatment of MCF-7 breast cancer cells with the novel small molecule ZNA 6.39
Long non-coding RNAs are central regulators of the IL-1b-induced inflammatory response in human lung fibroblasts 6.3
Messenger RNA profile analysis deciphers new Esrrb responsive genes in prostate cancer cells 6.29
Primary human trophoblast from term placenta 6.29
Intrahepatic MAIT cell gene expression revealed by RNA-seq 6.19
Proteostasis by STUB1/HSP70 complex controls sensitivity to androgen receptor targeted therapy in advanced prostate cancer 6.17
Proteostasis by STUB1/HSP70 complex controls sensitivity to androgen receptor targeted therapy in advanced prostate cancer (RNA-Seq) 6.17
Next Generation Sequencing of control (Untreated), PAN injured and Adriamycin injured human podocytes 6.15
Effect of PBK knockdown on C4-2 cell transcriptome 6.12
The Promyelocytic Leukemia Zinc Finger Dependent Transcriptome during Human Endometrial Stromal Cell Decidualization 6.09
Endometrial epithelial cell transcriptome response to co-culture with adipose stromal cells 6.09
Gene expression and 4sUDRB-seq for NF90/NF110 of human scramble and KD HeLa cells. 6.01
mRNA destabilization is the dominant effect of mammalian microRNAs by the time substantial repression ensues 6.0
mRNA destabilization is the dominant effect of mammalian microRNAs by the time substantial repression ensues (sequencing) 6.0
Appropriately Differentiated ARPE-19 Cells Regain a Native Phenotype and Similar Gene Expression Profile 5.97
Comparative transcriptomic analysis of human and Drosophila extracellular vesicles reveals extensive conservation 5.96
MiR-CLIP capture of a miRNA targetome uncovers a lincRNA H19-miR-106a interaction 5.93
Proteinase-Activated Receptor 4 (PAR4) mediates cell membrane blebbing in a Gaq/11, Gai independent, RhoA and ß-arrestin-dependent manner. 5.88
RNAseq of PRMT4KD in human cord blood derived CD34+ cells 5.88
Gene expression analysis of the impact of TDP-43 knockout in human cells. 5.87
Response of HEK293 Freestyle cells to 36 h of culture in Zn(II)-depleted Freestyle medium 5.86
Role for citron kinase in prostate cancer growth 5.83
RNA sequencing of GlyH-101-treated MCF-7 cell line 5.82
Comparison of the transcriptome and chromatin state between human cord blood HSC and human iPSC derived hematopoietic progenitor using next-generation sequencing 5.76
Determination of a comprehensive alternative splicing regulatory network and the combinatorial regulation by key factors during Epithelial-to-Mesenchymal Transition [RBM47 KD] 5.72
RNA-seq analyses of human prostate cancer cells 5.71
Transcriptomic Analysis Of circRNAs/miRNAs/mRNAs upon Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection 5.7
FMRP-associated MOV10 facilitates and antagonizes miRNA-mediated regulation 5.65
MYC interacts with the G9a histone methyltransferase to drive transcriptional repression and tumorigenesis 5.63
MYCL and EP400 are required for Max and MCPyV mediated gene activation 5.62
5hmC and gene expression data in breast cancer cell lines treated with an antioxidant 5.6
Hijacking of stress response machinery by oncogenes in acute leukaemia 5.59
Hijacking of stress response machinery by oncogenes in acute leukaemia [RNA-seq] 5.59
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [UNSWCD] 5.59
Cooperation of GRSF1 and the mitochondrial degradosome (hSuv3-PNPase complex) in degradation of mitochondrial RNA 5.59
Hepatocyte maturation 5.54
Transcriptome profiling of a mouse model of alveolar soft part sarcoma 5.53
Genetic disruption of COX-1 inhibits multiple oncogenic pathways 5.52
Identification of elevated A-to-I editing sites due to expression of an active ADAR3 mutant in human glioblastoma cells 5.48
Whole Transcriptomic Sequencing of Metastatic Castration Resistant Prostate Cancer Samples 5.45
Molecular Mechanisms of Endothelial Hyperpermeability 5.45
RNA sequencing of CACO-2 cells incubated with bifidobacteria grown on human milk oligosaccharides. 5.44
RNA-sequencing time course of Human Intestinal Epithelial Cells (HIECs) following knockdown of miR-30bcd using complementary locked nucleic acids 5.42
hsa-miR-503, hsa-miR-103, and hsa-miR-494 genome wide target profiles [RNA-Seq and RIP-Seq] 5.4
Genome-wide hsa-miR-503, hsa-miR-103, and hsa-miR-494 target profiles 5.4
A549 cells and MSR-A549 cells 5.38
mRNA expression profile of A549 cells and MSR-A549 cells with or without JQ1 treatment 5.38
The ALK downregulated target gene HBP1 and repressor of MYCN activity as synergistic target for combined PI3K/HDAC inhibition [RNA-Seq] 5.36
The ALK downregulated target gene HBP1 and repressor of MYCN activity as synergistic target for combined PI3K/HDAC inhibition 5.36
Genistein and bisphenol A exposure cause estrogen receptor 1 to bind thousands of binding sites in a cell type-specific manner 5.34
Human iPSC-based Modeling of Late-Onset Disease using Progerin-induced Aging 5.32
ELF4 is a target of miR-124 and promotes neuroblastoma proliferation and undifferentiated state 5.31
TT-seq captures simultaneous activation of eRNAs and promoters during T cell activation 5.31
RNA sequencing of heart samples of myotonic dystrophic (DM1) patients 5.29
Slit2 modifies VEGF-induced angiogenic responses in rabbit skeletal muscle by inducing capillary sprouting and decreasing vascular permeability via reduced eNOS activity 5.25
The ribonuclease activity of SAMHD1 is required for HIV-1 restriction 5.23
Diverse AR-V7 cistromes in castration-resistant prostate cancer are governed by HoxB13 5.23
RNA-seq melanoma 5.2
Pain-driven transcriptome changes in synovium of knee osteoarthritis patients 5.2
The β-catenin/CBP-antagonist ICG-001 inhibits pediatric glioma tumorigenicity in a Wnt-independent manner 5.17
RNA-seq in untreated and flagellin-treated Human Intestinal Myofibroblast cells (HIMF) 5.16
Cystathionine-β-Synthase Promotes Colon Carcinogenesis 5.12
IFN-g Regulates mTORC1, Cellular Metabolism and mRNA Translation to Potentiate Inflammatory Macrophage Activation 5.12
IFN-g Regulates mTORC1, Cellular Metabolism and mRNA Translation to Potentiate Inflammatory Macrophage Activation [RNA-Seq] 5.12
Systems-level analyses reveal a convergent pathway for progression of diffuse astrocytoma and potential role for resveratrol in delaying high-grade transformation 5.0
Identification of miRNA signatures during the differentiation of hESCs into retinal pigment epithelial cells 4.97
Neurofibromin is an Estrogen Receptor alpha Transcriptional Co-repressor in Breast cancer 4.88
Huntingtin aggregation impairs autophagy leading to Argonaute-2 accumulation and global microRNA dysregulation 4.87
Transcriptome of melanoma cell lines resistant to inhibition of the MAPK pathway. 4.81
Comparative total RNA and mRNA sequencing and systems analysis reveals nascent transcriptional response to early HIV-1 infection in a CD4+ T cell line 4.8
Oncogenic MYC induces a dependency on the spliceosome in human cancer 4.8
RNA-sequencing analysis for gene expression profiles affected by CASC9 knockdown 4.78
Differential effects of estrogen receptor beta isoforms on glioblastoma progression 4.75
Three-dimensional Oxabicycloheptene sulfonate targets the homologous recombination and repair programs through estrogen receptor α antagonism 4.75
RNA-seq analysis of HT-29, MCF10A, and MDA-MB-436 cells 4.74
Synaptic dysfunction in human neurons with Autism associated deletions in PTCHD1-AS 4.73
Transcriptional Profiling Identifies Novel Regulators of Macrophage Polarization [RNA-Seq] 4.72
Transcriptional Profiling Identifies Novel Regulators of Macrophage Polarization 4.72
Transcriptome of iPSC-derived Cerebral Organoids with Heterozygous Knockout in CHD8 4.71
TRIM24 is an oncogenic transcriptional co-activator of STAT3 in glioblastoma 4.7
Genes altered in expression by Cisplatin treatment in lung cancer cell lines 4.64
RNA-Seq study of Cell lines rendered resistant to idelalisib and ibrutinib 4.61
Transcriptome-wide discovery of microRNA binding sites in human brain by Ago2 HITS-CLIP 4.58
The effect of doxycycline-induced expression of host-cell-factor 2 (HCF-2) proteins on the global gene expression in HEK-293 cells 4.55
Comparing effects of perfusion and hydrostatic pressure on human chondrocytes using gene profiles 4.41
ICE1 promotes the link between splicing and nonsense-mediated mRNA decay 4.39
Transcriptomics-based drug repurposing approach identifies novel drugs against sorafenib-resistant hepatocellular carcinoma 4.35
Epigenome Editing by a CRISPR/Cas9-Based Acetyltransferase Activates Genes from Promoters and Enhancers 4.33
Androgen receptor functions as transcriptional repressor of Cancer Associated Fibroblast (CAF) activation 4.32
Androgen receptor functions as transcriptional repressor of Cancer Associated Fibroblast (CAF) activation [RNA-seq] 4.32
YTHDF1 Amplifies Wnt/β-Catenin Signaling to Promote Intestinal Stemness 4.3
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 4.25
Gene-Centric Functional Dissection of Human Genetic Variation Uncovers Regulators of Hematopoiesis 4.24
Androgen Receptor-regulated genes in prostate cancer cells 4.18
RNA-seq profiling identifies Androgen Receptor-regulated genes in prostate cancer cells 4.18
Improving fibroblast characterization using single-cell RNA sequencing: an optimized tissue disaggregation and data processing pipeline 4.17
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures 4.15
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures [RNA-Seq] 4.15
UBE3A-mediated regulation of imprinted genes and epigenome-wide marks in human neurons 4.14
Epigenetic reprogramming of immune cells in women with PCOS impact genes controlling reproductive function 4.06
Epigenetic reprogramming of immune cells in women with PCOS impact genes controlling reproductive function [RNAseq] 4.06
lncRNA-PCAT1 knockdown effect on the gene expression of androgen independent LNCaP (LNCaP-AI) cell line 4.03
Identification of monocyte-like precursors of granulocytes as a mechanism for accumulation of PMN-MDSC in cancer 4.02
An evolutionarily conserved function of polycomb silences the MHC class I antigen presentation pathway and enables immune evasion in cancer [RNA-Seq] 4.0
An evolutionarily conserved function of polycomb silences the MHC class I antigen presentation pathway and enables immune evasion in cancer 4.0
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques [MB157_RNA-seq] 3.95
The NORAD lncRNA assembles a topoisomerase complex critical for genome stability 3.92
The NORAD lncRNA assembles a topoisomerase complex critical for genome stability [RNA-seq] 3.92
Mapping interactions for the TNIP2 hub protein 3.91
The age and genomic integrity of neurons after cortical stroke in humans 3.9
Direct identification of endogenous SMG6 targets and a preferred motif spanning SMG6 cleavage sites by parallel analysis of RNA ends in human cells 3.89
Gene expression profiles of PD1-high, PD1-intermediate, and PD1-negative tumor-infiltrating CD8 T cells in hepatocellular carcinoma 3.88
The mRNA expression analysis of psoriasis skin lesion mesenchymal stem cell 3.82
CRISPR/Cas9-mediated ASXL1 mutation in U937 cells perturbs myeloid differentiation 3.82
Proximity-CLIP provides a snapshot of occupied cis-acting elements on RNA in different subcellular compartments on a transcriptome-wide scale 3.82
CNOT1 and Transcriptomic Landscape of a HeLa Cell Line 3.8
Gene expression profiles of 4-1BB+PD-1-high, 4-1BB-PD-1-high, and PD-1-int tumor-infiltrating CD8 T cells in hepatocellular carcinoma 3.78
Transcriptome analysis of fetal Klinefelter testis tissue samples compared to controls 3.77
RNA Missplicing in Fuchs Endothelial Corneal Dystrophy 3.76
TSLP acts on neutrophils to drive complement-mediated killing of methicillin-resistant Staphylococcus aureus 3.76
Genome-wide analysis of the Integrator complex (HTS) 3.75
Genome-wide analysis of the Integrator complex 3.75
Interaction between mitoNEET and NAF-1 in cancer cells 3.74
Reprogramming by de-bookmarking somatic transcriptional program via targeting the BET bromodomains 3.73
Mapping cis-regulatory chromatin contacts in neural cells links neuropsychiatric disorder risk variants to target genes 3.71
Mapping cis-regulatory chromatin contacts in neural cells links neuropsychiatric disorder risk variants to target genes [RNA-Seq] 3.71
Next generation sequencing on knockdown of AC093323.3 in lung cancer cells 3.7
Gene expression analysis of C4-2 cells treated with ACLY inhibitor and Enzalutamide 3.66
Conservative alteration of chromosomal expression pattern across human solid tumor types 3.66
CT Irradiation Induced Changes of Gene Expression within Peripheral Blood Cells 3.63
ZMYND8 reads the dual histone mark H3K4me1-H3K14ac to antagonize the expression of metastasis-linked genes 3.62
Epigenetic programming during monocyte to macrophage differentiation and trained innate immunity 3.6
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (separate infection) 3.57
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer 3.52
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer (RNA-seq) 3.52
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [SLAM-Seq] 3.49
STX4 Over-Expression in Human islets 3.46
Mapping of DHT-responsive or -independent AR-binding sites induced by activated Src in prostate cancer cell lines [RNA-seq] 3.45
Mapping of DHT-responsive or -independent AR-binding sites induced by activated Src in prostate cancer cell lines 3.45
Identification of an IL-1-induced gene expression pattern in AR+ PCa cells that mimics the molecular phenotype of AR- PCa cells 3.43
RNA sequencing of prostate cancers reveal insights on the prognostic significance of visibility on multi-parametric MRI 3.4
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L [RNA-seq C-terminal mutant] 3.38
Ribosome profiling of A549 cells depleted of RPLP1 and RPLP2 and infected with DENV. 3.32
Global Transcriptional analysis of human spinal cord and neocortical neuroepithelial stem (NES) cells 3.3
Gene expression and genome-wide location analysis of breast cancer cell-lines 3.28
Gene expression analysis of breast cancer cell-lines 3.28
Identification of a LIF-responsive replication-competent human β cell 3.28
Age-Related Gene Expression Changes in Prostate Cancer Patients 3.24
Age-Related Gene Expression Changes in Prostate Cancer Patients [RNA-Seq] 3.24
MYCi361 regulates MYC target genes 3.22
Capturing the Interactome of Newly Transcribed RNA (RICK) 3.2
Capturing the Interactome of Newly Transcribed RNA 3.2
The effect of insulin on mRNA transcription of human pluripotent stem cells 3.19
TCF21 and Aryl-hydrocarbon receptor gene cooperate to activate a pro-atherosclerotic gene expression program 3.14
Dual inhibition of HDMX and HDM2 as a Therapeutic Strategy in Leukemia 3.13
FBP2 inhibits sarcoma progression by restraining mitochondrial biogenesis 3.12
Transcriptome analysis of BAP1 knockout and restoration 3.12
Expression profiles of restoration of BAP1 in a BAP1 deficient cell line 3.12
Tunable protein synthesis by transcript isoforms in human cells (Transcript Isoforms in Polysomes sequencing: TrIP-seq) 3.08
TNFα Signaling Exposes Latent Estrogen Receptor Binding Sites in Breast Cancer Cells 3.07
TNFα Signaling Exposes Latent Estrogen Receptor Binding Sites in Breast Cancer Cells [GRO-seq] 3.07
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT, U0126, CYHX, ActD, EGF, FGF, or IGF and labelled with 4SU 3.03
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT and labelled with 4SU 3.03
mRNA sequencing of highly and lowly metastatic human colorectal cancer PDXs 3.02
Comprehensive Transcriptome Analysis of Cerebral Cavernous Malformation Across Multiple Species and Genotypes 3.0
RNA:DNA hybrids in the human genome have distinctive nucleotide characteristics, chromatin composition, and transcriptional relationships 2.93
RNA:DNA hybrids in the human genome have distinctive nucleotide characteristics, chromatin composition, and transcriptional relationships (RNA-seq) 2.93
Circular RNA profiling reveals the different distribution/characteristic and possible transport mechanism among the subcellular fractions 2.93
Active translatome profiling with RiboLace in MCF7 cells 2.93
The hematopoietic master transcription factor PU.1 requires its interaction with the SWI/SNF remodeler to access chromatin de novo 2.87
The hematopoietic master transcription factor PU.1 requires its interaction with the SWI/SNF remodeler to access chromatin de novo [RNA-seq] 2.87
CHD1 loss sensitizes prostate cancer to DNA damaging therapy by promoting error-prone double-strand break repair 2.86
Tracing Enhancer Networks using Epigenetic Traits (TENET) 2.85
Small extracellular vesicles are key regulators of non-cell autonomous intercellular communication in senescence via the interferon protein, IFITM3 2.82
Genome-wide maps of WT and over-expressing CenH3/CENP-A in Human HeLa S3 cells 2.8
RNA editing in nascent RNA affects pre-mRNA splicing 2.69
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L [RNA-Seq KO] 2.67
Mesenchymal stem/stromal cell engulfment reveals metastatic advantage in breast cancer 2.63
RNA-seq analysis of PRMT5-regulated genes in irradiated/non-irradiated LNCaP cells 2.63
Dynamic gene regulatory networks of human myeloid differentiation [RNA-seq_siRNA] 2.6
N6-methyladenosine mRNA marking promotes selective translation of regulons required for human erythropoiesis[Ribosome Profiling] 2.59
METTL3 and WTAP 2.58
CSL 2.58
CSL RNA-Seq on HKC and SCC cell lines 2.58
A Novel Population of Human Cardiac Resident Mesenchymal Stem Cells 2.56
RNA-seq transcriptonal profiling in human K562 cells with or without dCas9 and sgRNAs 2.56
In situ CAPTURE of chromatin interactions by biotinylated dCas9 2.56
Dynamic gene expression in T-ALL following treatment and release of gamma-secretase inhibition [GRO-Seq] 2.54
Recapitulation of Human Neural Microenvironment Signatures in iPSC-Derived NPC 3D Differentiation 2.52
Expression profiling of lncRNAs, miRNAs and mRNAs and their differential expression in leiomyoma using next generation RNA sequencing 2.52
Gene expression profiling in metabolically heterogeneous human lung tumors 2.51
Molecular analysis of renal cell carcinoma with unclassfied histology 2.46
Molecular analysis of renal cell carcinoma with unclassfied histology [gene expression] 2.46
C9/ALS Human Embryonic Stem Cells and C9/ALS Induced Pluripotent Stem Cells 2.42
Functional Significance of U2AF1 S34F Mutation in Lung Adenocarcinomas 2.42
Global Long Terminal Repeat activation participates in establishing the unique gene expression program of classical Hodgkin Lymphoma [Primary RNA-Seq] 2.37
3’READS+, a sensitive and accurate method for 3’ end sequencing of polyadenylated RNA 2.35
Vammin induces a highly efficient angiogenic response through VEGFR-2/NRP-1 and bypasses the regulatory function of VEGFR-1 2.35
eVIP2: Expression-based variant impact phenotyping to predict the function of gene variants 2.32
Single amino acid change underlies distinct roles of H2A.Z subtypes in human syndrome 2.31
Long non-coding RNA SMILR regulates genes involved in cytokinesis in human vascular smooth muscle cell 2.3
Self-organized cerebral organoids with human specific features predict effective drugs to combat Zika virus infection 2.29
Self-organized cerebral organoids with human specific features predict effective drugs to combat Zika virus infection [RNA-seq] 2.29
Topoisomerase 1 inhibition suppresses inflammatory genes and protects from death by inflammation 2.28
Topoisomerase 1 inhibition suppresses inflammatory genes and protects from death by inflammation (RNA-Seq) 2.28
ELP1 splicing correction reverses proprioceptive sensory loss in familial dysautonomia 2.27
Dual RNA-seq of diverse human, mouse and pig cell-types infected with various Salmonella strains 2.24
Dual RNA-seq – High-resolution comparative Dual RNA-seq time-course 2.24
Identification of the RB loss-induced transcriptome in prostate cancer [RNA] 2.2
Identification of the RB loss-induced transcriptome and E2F1 cistrome in prostate cancer 2.2
Expression analysis of PC3 cells treated with scramble AON or AON directed against MBNL1 2.1
A Non-Canonical Nuclear Activity Triggered by Small RNAs and Argonaute Proteins in Human Cells 2.09
Effect of BCL11B knockdown on transcriptome of human T-cell precursors 2.08
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 2.08
Assessing placental maturity through histological and transcriptomic analyses in idiopathic spontaneous preterm birth 2.03
Rnase L reprograms translation by widespread mRNA turnover escaped by antiviral mRNAs 1.98
Zika virus directly infects human peripheral neurons and induces cell death 1.96
Arnica montana stimulates extracellular matrix gene expression in human macrophages differentiated to wound-healing phenotype. Tested on 5 concentrations. 1.95
Analysis of human ES cell differentiation establishes that the dominant isoforms of the lncRNAs RMST and FIRRE are circular 1.93
RNA-Seq characterization of human H1-derived NPC differentiation timecourse 1.9
RNA-sequencing of the brain transcriptome implicates dysregulation of neuroplasticity, circadian rhythms, and GTPase binding in bipolar disorder 1.89
RNA-seq from primary skin fibroblasts, derived of matched pairs of middle and late donor age 1.89
Aging signatures developed from a longitudinal study design are dominated by reduced transcription of genes involved in protein synthesis. 1.89
Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates 1.87
Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates (part 4) 1.87
Sequencing of freshly produced RNA following exposure of cells to DNA damage-inducing UV mimetic 4-hydroxyaminoquinolone (4-NQO) 1.86
A monocyte gene expression signature in the early clinical course of Parkinson’s disease 1.85
Anti-Inflammatory Effects of Budesonide in Human Fetal Lung 1.84
nELAVL HITS-CLIP in Alzheimer's Disease patients 1.78
Bromodomain protein BRD4 is a transcriptional repressor of autophagy and lysosomal function 1.77
Structural basis for human respiratory syncytial virus NS1-mediated modulation of host responses 1.77
C19ORF66 broadly escapes viral-induced endonuclease cleavage and restricts Kaposi’s Sarcoma Associated Herpesvirus (KSHV) 1.74
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. 1.7
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. [RNA-Seq] 1.7
Identification of HOXB13 target genes responsive to BET inhibitors 1.65
Single Cell Sequencing Reveals Gene Expression Signatures Associated with Bone Marrow Stromal Cell Subpopulations and Time in Culture [NGS_bulk cell RNA-seq] 1.65
Transcriptional profiling identifies differential expression of long non-coding RNAs in Jo-1 associated and inclusion body myositis 1.65
RNA-seq data of small cell carcinoma of the bladder (SCCB) /urothelial carcinoma (Non-SCCB) clinical samples, and bladder-PARCB cell lines 1.62
Disease modelling of core pre-mRNA splicing factor haploinsufficiency 1.6
Dilated cardiomyopathy vs Myocarditis 1.59
Canonical and non-canonical regulatory roles of androgen receptor variant 7 in prostate cancer 1.57
Repression of stress-induced LINE-1 expression protects cancer cell populations from lethal drug-exposures 1.57
Repression of stress-induced LINE-1 expression protects cancer cell populations from lethal drug-exposures [RNA-Seq] 1.57
FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer [RNA-seq] 1.55
FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer 1.55
Transcriptome profile of ATP7B KO cells and WT cells treated with Copper (Cu) to study Autophagy as a pro-survival mechanism in Wilson disease 1.55
MicroRNA-125a-5p overexpression in human macrophages 1.51
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia 1.5
RNA-seq and small RNA-seq analysis of BORIS/CTCFL knockdown in K562 cell line 1.49
RNA-seq analysis of BORIS/CTCFL knockdown in K562 cell line 1.49
Genome wide association study of bone size yields eleven loci that also affect height, bone density, osteoarthritis and fractures 1.45
RNA sequencing of human mammary epithelial cells 1.4
Wide-spread disruption of transcription termination in HSV-1 infection: Next-generation sequencing of translational activityd by ribosome profiling 1.38
single cell RNA-seq from GM12878 (ENCSR673UIY) 1.25
Networks of cultured iPSC-derived neurons reveal the human synaptic activity-regulated adaptive gene program 1.23
Gene expression profiling associated with knockdown of RNF20 in human normal and malignant lung epithelial cell lines 1.23
Histone acetyltransferase p300 induces de novo super-enhancers to drive cellular senescence 1.23
Histone acetyltransferase p300 induces de novo super-enhancers to drive cellular senescence [RNA-seq] 1.23
Gene expression profiling by RNA-seq in hTert-HME1 cell line treated with control or BRCA2 siRNAs and grown with or without EGF (epithelial growth factor) II 1.2
The LRF/ZBTB7A transcription factor is a BCL11A-independent repressor of fetal hemoglobin 1.13
RNA-seq of exosomes identifies lncRNA profiles that distinguish early-stage esophageal squamous cell carcinoma (ESCC) from non-malignant esophagitis 1.11
Impact of library preparation on downstream analysis and interpretation of RNA-seq data: comparison between Illumina PolyA and NuGEN Ovation protocol 1.1
HEK293 TFAM Knockout Expression Study 1.02
The splicing factor RBM25 controls MYC activity in Acute Myeloid Leukemia 0.98
Complement protein C1q modulates macrophage molecular signaling and inflammatory responses during ingestion of atherogenic lipoproteins 0.98
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia [inhibitor MRT199665] 0.97
Next Generation Sequencing (RNA-Sequencing) for the analysis of RUNX3 targets in H460, H460-ERT2-RUNX3 WT and H460-ERT2-RUNX3 MT(K94/171R mutation) 0.96
DAOY-Notch1/Notch2 knockout: transcriptome comparison 0.94
Effect of Ro 08-2750 treatment on gene expression of human leukemia cell lines MOLM13 and K562 0.89
Global gene expression profiling from LeuCAG3'tsRNA depleted- HeLa and HCT-116 cell lines through 50 base pair paired-end RNA-seq 0.88
Oligogenic inheritance of congenital heart disease involving a NKX2-5 modifier [human] 0.86
Oligogenic inheritance of congenital heart disease involving a NKX2-5 modifier 0.86
Reducing the structure bias of RNA-Seq reveals a large number of non-annotated non-coding RNA 0.84
Transcriptome sequencing wide functional analysis of human mesenchymal stem cells 0.82
p63 controls the enhancer landscape during keratinocyte differentiation 0.78
Genome-wide modelling of transcription kinetics reveals patterns of RNA processing delays 0.77
Effect of venetoclax, tedizolid, and combination treatment on gene expression in a venetoclax-resistant AML cell line 0.76
RNA-seq reveals abundant circRNA, lncRNA and mRNA in blood exosomes of patients with colorectal carcinoma 0.75
Muscle transcriptome analysis following Total Knee Arthroplasty with Tourniquet 0.74
miR-155 plays a crucial role in ALS and is an immune therapeutic target [RNA-Seq] 0.7
Targeting miR-155 restores abnormal microglia and attenuates disease in SOD1 mice 0.7
Genome-wide search for differentially expressed RNAs responsible for the effects induced by Ebola virus replication and transcription 0.69
4sUDRB-seq: measuring transcription elongation and initiation genomewide 0.69
Genome-wide Analysis of Chromatin Interactions in Human Cells 0.67
Transcriptome-profiling (RNA-seq) and Ribosome-profiling (Ribo-seq) in proliferation, quiescence, senescence and transformed states. 0.64
An intramolecular salt bridge linking TDP43’s RNA recognition motifs dictates RNA binding, protein stability and TDP43-dependent neurodegeneration 0.64
Hemogenic Endothelium transcriptome along the timeline of hESC differentiation 0.64
Integration of ATAC-seq and RNA-seq Identifies Human Alpha Cell and Beta Cell Signature Genes 0.56
HEK293 Heat-shock experiment 0.45
Toxoplasma gondii infection of human retinal pigment epithelial cells 0.45
T-bet recruits P-TEFb to super-enhancers to regulate T helper cell differentiation 0.45
T-bet recruits P-TEFb to super-enhancers to regulate T helper cell differentiation (RNA-Seq) 0.45
A single cell reference map for human blood and tissue T cell activation 0.43
Comprehensive comparative analysis of 5’ end RNA sequencing methods 0.42
Differential LINE-1 retrotransposition in induced pluripotent stem cells between humans and great apes 0.4
Modulation of nonsense-mediated decay by rapamycin 0.39
Recovery and analysis of nascent RNA 0.39
The oncogenic BRD4-NUT chromatin regulator drives aberrant transcription within large topological domains 0.39
Functional genomic analysis of the haploinsufficient tumor suppressor, CUX1 0.38
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (pooled infection) 0.36
Intragenic DNA methylation modulates alternative splicing by recruiting MeCP2 to promote exon recognition [RNA-Seq] 0.35
Intragenic DNA methylation modulates alternative splicing by recruiting MeCP2 to promote exon recognition 0.35
A Hybrid Mechanism of Action for BCL6 in B Cells Defined by Formation of Functionally Distinct Complexes at Enhancers and Promoters 0.34
Improved genome-wide mapping of uncapped and cleaved transcripts in eukaryotes—GMUCT 2.0 0.33
Tri-mannose grafting of chitosan nanocarriers remodels the macrophage response to bacterial infection 0.31
Biomarkers of Cavernous Angioma with Symptomatic Hemorrhage (CASH) [RNA-seq] 0.26
Biomarkers of Cavernous Angioma with Symptomatic Hemorrhage (CASH) 0.26
RNA-Seq with and without RNase treatment in PCa cell lines 0.26
Comprehensive comparative analysis of RNA sequencing methods for degraded or low input samples 0.19
A MYC/GCN2/eIF2alpha negative feedback loop limits protein synthesis to prevent MYC-dependent apoptosis in colorectal cancer 0.18
Transcriptome analysis in a radiosensitive and a radioresistant cell line after ionizing radiation 0.17
Hyperactive mTOR and MNK1 phosphorylation of eIF4E confer tamoxifen resistance and estrogen independence through selective mRNA translation reprogramming 0.13
Neuronal deletion of Gtf2i, associated with Williams syndrome, causes behavioural and myelin alterations rescuable by a remyelinating drug [human] 0.1
Neuronal deletion of Gtf2i, associated with Williams syndrome, causes behavioural and myelin alterations rescuable by a remyelinating drug 0.1
RNA-seq and small RNA-seq from WT and ADAR1 knockdown H9 lines and their differentiation to specific types of neurons 0.09
Single cell RNA-seq resolves lineage-specific activation dynamics of human blood and tissue T cells 0.07
rG4-seq reveals widespread formation of G-quadruplex structures in the human transcriptome 0.07
Expression changes in MAPKi resistant M229 melanoma lines co-cultured with PD-1 overexpressing HEK293T cells [CellLine.FPKM.batch5] 0.06
Myc activation coordinates gene transcription and protein translation responses 0.04
Modeling Human Cancer-induced Cachexia (Human) 0.04
Recurrent alterations of TNFAIP3 (A20) in T-cell large granular lymphocytic leukemia 0.04
RNAseq of Breast cancer PDX samples 0.03
ALS implicated protein TDP-43 sustains levels of STMN2 a mediator of motor neuron growth and repair 0.02
A toxicogenomics approach to screen chlorinated flame retardants tris(2-chloroethyl) phosphate and tris(2-chloroisopropyl) phosphate for potential health effects 0.02
The Small Molecule ISRIB Reverses the Effects of eIF2α Phosphorylation on Translation and Stress Granule Assembly 0.01


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation